{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-277147","form_type":"8-K","ticker":"KRRO","cik":"0001703647","company_name":"Korro Bio, Inc.","filed_at":"2023-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.108453+00:00","generated_at":"2026-06-08T03:46:46.140892+00:00","sec_items":["5.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Korro Bio enters new employment agreements with CEO and CFO with enhanced change-in-control severance","bullets":["CEO Ram Aiyar: base $498,487, target bonus 45% of base; CFO Vineet Agarwal: base $426,483, target bonus 35%.","Outside CIC severance: CEO 12 months base + pro rata bonus + 12 months COBRA; CFO 9 months base + pro rata bonus + 9 months COBRA.","Within CIC severance: CEO 18 months base + 1.5x bonus + accelerated vesting; CFO 12 months base + 1.0x bonus + accelerated vesting.","Agreements supersede prior offer letters, formalizing compensation previously disclosed; effective November 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-277147","json":"https://secwatch.observer/filing/0001193125-23-277147.json","markdown":"https://secwatch.observer/filing/0001193125-23-277147.md","text":"https://secwatch.observer/filing/0001193125-23-277147.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1703647/000119312523277147/0001193125-23-277147-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1703647/000119312523277147/d416540d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T03:46:46.140892+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}